Skip to content

MWM Technique in Patients With Knee OA

Effects of Mulligan Mobilization With Movement (MWM) Technique in Patients With Knee Osteoarthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06280365
Enrollment
30
Registered
2024-02-28
Start date
2024-05-06
Completion date
2024-07-30
Last updated
2024-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mobilization

Keywords

Knee Osteoarthritis, Mobilization, Proprioception, Pain

Brief summary

The aim of this study is to investigate the effect of the MWM technique on pain, normal joint movement, proprioception and quality of life in patients with knee osteoarthritis (OA).

Detailed description

The aim of this study is to investigate the effect of the MWM technique on pain, normal joint movement, muscle strength, proprioception, mobility, balance, functionality and quality of life in patients with knee OA.

Interventions

Sponsors

Okan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* being diagnosed with knee osteoarthritis, * being diagnosed with knee OA at the earliest 6 months ago

Exclusion criteria

* Participants who were pregnant, * had knee surgery, had an infection, * had a pacemaker, had an infraction, * had cancer, or were receiving corticosteroid treatment were excluded from the study

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale (VAS)4 week change in pain intensityVAS, which digitizes parameter values that cannot be measured numerically, was used to evaluate the pain intensity of the participants. The two extreme values of the parameter to be measured are written on the scale as 0 and 10. The person is asked to mark the value that best suits him/her on the scale. For pain, no pain and very severe pain; It is specified as 0 and 10. The person chooses a value according to his/her pain
Short form-36 (SF-36)4-week change in quality of lifeSF-36, developed in 1992, consists of 36 items providing measurement to the following 8 dimensions: physical functioning (10 items), social functioning (2 items), role limitations due to physical problems (4 items), role limitations due to emotional problems (3 items), mental health (5 items), energy/vitality (4 items), pain (2 items), and general health perception (5 items). An increase in the score indicates a higher rate of improvement in health status.
Western Ontario and Mcmaster Universities Osteoarthritis Index (WOMAC)4-weekThis survey is conducted to evaluate how much the routine activities in the participants' lives are affected by the knee problem. The survey included the following parameters: pain, physical function, and stiffness. A Likert system ranging from 1 to 5 is used. As the value increases, the intensity of the parameters increases
Evaluation of proprioception4-week change in proprioceptionTo assess the participants' sense of proprioception, the method of actively reproducing the passive position without supporting the limb was used. In this assessment, where the angle is measured with a goniometer, the person closes their eyes. The limb is passively moved to the target angle and the person is asked to concentrate on the position. After 10 seconds, the starting point of the movement is returned. The person tries to find the target angle by actively moving the same limb. If the angle achieved at the end of the movement is different from the target angle, the difference is recorded as the deviation angle (used to 15° and 45° knee flexion).
The range of motion4-weekA goniometer (Baseline plastic goniometer), which provides numerical and objective results, was used to measure the range of motion of the participants. Knee flexion for normal range of motion in the knee region and knee extension angles were evaluated.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026